Eli Lilly (Japan)

514 papers and 7.8k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (Japan) have published 514 papers, which have received a total of 7.8k indexed citations. Scholars at this organization have produced 116 papers in Oncology, 109 papers in Pulmonary and Respiratory Medicine and 105 papers in Endocrinology, Diabetes and Metabolism on the topics of Diabetes Treatment and Management (77 papers), Diabetes Management and Research (58 papers) and Colorectal Cancer Treatments and Studies (45 papers). Their work is cited by papers focused on Oncology (2.0k citations), Endocrinology, Diabetes and Metabolism (1.6k citations) and Molecular Biology (1.5k citations). Authors at Eli Lilly (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Blood and PLoS ONE. Some of Eli Lilly (Japan)'s most productive authors include Takeshi Imaoka, Masayo Sato, Sotaro Enatsu, Hiroyuki Enomoto and Kaname Ueda.

In The Last Decade

Fields of papers published by authors at Eli Lilly (Japan)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Eli Lilly (Japan) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Eli Lilly (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (Japan) more than expected).

Rankless by CCL
2025